HCG (Human Chorionic Gonadotropin) vs VIP (Vasoactive Intestinal Polypeptide)
Updated September 22, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of HCG (Human Chorionic Gonadotropin) and VIP (Vasoactive Intestinal Polypeptide) (also searched as VIP (Vasoactive Intestinal Polypeptide) vs HCG (Human Chorionic Gonadotropin)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
HCG (Human Chorionic Gonadotropin) centers on metabolic, while VIP (Vasoactive Intestinal Polypeptide) leans toward inflammation. On indexed research, HCG (Human Chorionic Gonadotropin) is ahead (HCG (Human Chorionic Gonadotropin): 45 studies, Human clinical; VIP (Vasoactive Intestinal Polypeptide): 34, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •HCG (Human Chorionic Gonadotropin) is strongest for metabolic; VIP (Vasoactive Intestinal Polypeptide) for inflammation.
- •Evidence: HCG (Human Chorionic Gonadotropin) Human clinical (45 studies) vs VIP (Vasoactive Intestinal Polypeptide) Human clinical (34).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
LH receptor agonist | Fertility support
Neuropeptide | Modulates immune responses
HCG (Human Chorionic Gonadotropin) vs VIP (Vasoactive Intestinal Polypeptide): side-by-side
| Metric | HCG (Human Chorionic Gonadotropin) | VIP (Vasoactive Intestinal Polypeptide) |
|---|---|---|
| Class | Healing | Neuro |
| Regulatory status | FDA-approved | Research use only |
| Evidence grade | Human clinical | Human clinical |
| Studies indexed | 45 | 34 |
| Research level | FDA Approved | Well Studied |
| Strongest effect | Metabolic & appetite | Inflammation & immune |
| Healing & recovery | 1.0 | 3.0▲ |
| Muscle & body comp | 1.0▲ | 1.0▲ |
| Metabolic & appetite | 2.0▲ | 2.0▲ |
| Neuro & mood | 1.0 | 4.0▲ |
| Sleep & circadian | 0.0 | 3.0▲ |
| Inflammation & immune | 1.0 | 4.0▲ |
| Skin & aesthetics | 1.0▲ | 1.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | HCG (Human Chorionic Gonadotropin) | VIP (Vasoactive Intestinal Polypeptide) |
|---|---|---|
| Mechanism | LH receptor agonist | VPAC1 and VPAC2 receptor agonist |
| Route | Subcutaneous injection | — |
| Half-life | ~24 hours | — |
| Time to peak | 6–24 hours | — |
| Duration of action | Varies | — |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is HCG (Human Chorionic Gonadotropin)?
HCG (Human Chorionic Gonadotropin) is a glycoprotein hormone produced by the placenta during pregnancy. It is structurally similar to luteinizing hormone (LH) and plays a crucial role in regulating reproductive processes in both men and women. HCG is primarily used in clinical settings to stimulate endogenous testosterone production in men with hypogonadism and to support fertility treatments in women, particularly in assisted reproductive technologies such as in vitro fertilization (IVF).
Full HCG (Human Chorionic Gonadotropin) profile, mechanism & studies →What is VIP (Vasoactive Intestinal Polypeptide)?
Vasoactive Intestinal Peptide | Neuropeptide
Full VIP (Vasoactive Intestinal Polypeptide) profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | VIP (Vasoactive Intestinal Polypeptide) | 3.0/5 effect signal |
| Muscle | Even | Both ~1.0/5 |
| Metabolic | Even | Both ~2.0/5 |
| Neuro | VIP (Vasoactive Intestinal Polypeptide) | 4.0/5 effect signal |
| Sleep | VIP (Vasoactive Intestinal Polypeptide) | 3.0/5 effect signal |
| Inflammation | VIP (Vasoactive Intestinal Polypeptide) | 4.0/5 effect signal |
| Skin | Even | Both ~1.0/5 |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack HCG (Human Chorionic Gonadotropin) and VIP (Vasoactive Intestinal Polypeptide)?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
HCG (Human Chorionic Gonadotropin) vs VIP (Vasoactive Intestinal Polypeptide): side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
HCG (Human Chorionic Gonadotropin) has 45 approved studies indexed (Human clinical), and VIP (Vasoactive Intestinal Polypeptide) has 34 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is HCG (Human Chorionic Gonadotropin) or VIP (Vasoactive Intestinal Polypeptide) better?
It depends on your goal. HCG (Human Chorionic Gonadotropin) is strongest for metabolic; VIP (Vasoactive Intestinal Polypeptide) for inflammation. HCG (Human Chorionic Gonadotropin) has more indexed studies (45). See the goal-by-goal breakdown above.
Is HCG (Human Chorionic Gonadotropin) or VIP (Vasoactive Intestinal Polypeptide) better for weight loss?
They score similarly on the metabolic/appetite axis in the community data.
Is HCG (Human Chorionic Gonadotropin) or VIP (Vasoactive Intestinal Polypeptide) better for muscle?
Both land close on the muscle & body-composition axis.
Which has more research, HCG (Human Chorionic Gonadotropin) or VIP (Vasoactive Intestinal Polypeptide)?
HCG (Human Chorionic Gonadotropin) has 45 approved studies indexed (Human clinical); VIP (Vasoactive Intestinal Polypeptide) has 34 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack HCG (Human Chorionic Gonadotropin) and VIP (Vasoactive Intestinal Polypeptide)?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of HCG (Human Chorionic Gonadotropin) vs VIP (Vasoactive Intestinal Polypeptide)?
HCG (Human Chorionic Gonadotropin): no community-reported effects logged yet. VIP (Vasoactive Intestinal Polypeptide): none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is HCG (Human Chorionic Gonadotropin) or VIP (Vasoactive Intestinal Polypeptide) FDA-approved?
HCG (Human Chorionic Gonadotropin) is FDA-approved. VIP (Vasoactive Intestinal Polypeptide) is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is VIP (Vasoactive Intestinal Polypeptide) better than HCG (Human Chorionic Gonadotropin)?
For inflammation, VIP (Vasoactive Intestinal Polypeptide) has the edge; for metabolic, HCG (Human Chorionic Gonadotropin) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 22, 2026.